UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 72

Sortiert nach

Discovery and development of first in class antifungal caspofungin (CANCIDAS®)-A case study

Natural product reports, 2014-01, Vol.31 (1), p.15-34

2014

Volltextzugriff (PDF)

Bifunctional Small Molecules Enhance Neutrophil Activities Against Aspergillus fumigatus in vivo and in vitro

Frontiers in immunology, 2019-04, Vol.10, p.644-644

2019

Volltextzugriff (PDF)

Preclinical Evaluation of the Stability, Safety, and Efficacy of CD101, a Novel Echinocandin

Antimicrobial agents and chemotherapy, 2016-11, Vol.60 (11), p.6872-6879

2016

Volltextzugriff (PDF)

The First Stereoselective Total Synthesis of Quinine

Journal of the American Chemical Society, 2001-04, Vol.123 (14), p.3239-3242

2001

Volltextzugriff (PDF)

The use of stable-isotopically labeled oleic acid to interrogate lipid assembly in vivo: assessing pharmacological effects in preclinical species

Journal of lipid research, 2011-06, Vol.52 (6), p.1150-1161

2011

Volltextzugriff (PDF)

Ibrexafungerp: An orally active β-1,3-glucan synthesis inhibitor

Bioorganic & medicinal chemistry letters, 2021-01, Vol.32, p.127661-127661, Article 127661

2021

Volltextzugriff (PDF)

Development of Novel Immunoprophylactic Agents against Multidrug-Resistant Gram-Negative Bacterial Infections

Antimicrobial agents and chemotherapy, 2021-10, Vol.65 (11), p.e0098521-e0098521

2021

Volltextzugriff (PDF)

Novel N-Arylpyrazolo[3,2-c]-Based Ligands for the Glucocorticoid Receptor: Receptor Binding and in Vivo Activity

Journal of medicinal chemistry, 2004-05, Vol.47 (10), p.2441-2452

2004

Volltextzugriff (PDF)

11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice

The Journal of experimental medicine, 2005-08, Vol.202 (4), p.517-527

2005

Volltextzugriff (PDF)

MK-5204: An orally active β-1,3-glucan synthesis inhibitor

Bioorganic & medicinal chemistry letters, 2020-09, Vol.30 (17), p.127357-127357, Article 127357

2020

Volltextzugriff (PDF)

CTC-177, a novel drug–Fc conjugate, shows promise as an immunoprophylactic agent against multidrug-resistant Gram-negative bacterial infections

JAC-antimicrobial resistance, 2024-08, Vol.6 (4), p.dlae100

2024

Volltextzugriff (PDF)

Accelerating the discovery of DGAT1 inhibitors through the application of parallel medicinal chemistry (PMC)

Bioorganic & medicinal chemistry letters, 2019-06, Vol.29 (11), p.1380-1385

2019

Volltextzugriff (PDF)

Novel orally active inhibitors of β-1,3-glucan synthesis derived from enfumafungin

Bioorganic & medicinal chemistry letters, 2015-12, Vol.25 (24), p.5813-5818

2015

Volltextzugriff (PDF)

Benzimidazole-based DGAT1 inhibitors with a [3.1.0] bicyclohexane carboxylic acid moiety

Bioorganic & medicinal chemistry letters, 2019-05, Vol.29 (10), p.1182-1186

2019

Volltextzugriff (PDF)

Synthesis and biological evaluation of antifungal derivatives of enfumafungin as orally bioavailable inhibitors of β-1,3-glucan synthase

Bioorganic & medicinal chemistry letters, 2012-11, Vol.22 (22), p.6811-6816

2012

Volltextzugriff (PDF)

11 beta -HSD1 inhibition reduces atherosclerosis in mice by altering proinflammatory gene expression in the vasculature

Physiological genomics, 2013-01, Vol.45 (1), p.47-57

2013

Volltextzugriff (PDF)

Phenylcyclobutyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I

Bioorganic & medicinal chemistry, 2008-06, Vol.18 (11), p.3412-3416

2008

Volltextzugriff (PDF)

Adamantyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1

Bioorganic & medicinal chemistry letters, 2005-10, Vol.15 (19), p.4359-4362

2005

Volltextzugriff (PDF)

11β-HSD1 inhibition reduces atherosclerosis in mice by altering proinflammatory gene expression in the vasculature

Physiological genomics, 2013-01, Vol.45 (1), p.47-57

2013

Volltextzugriff (PDF)

Section Review: Anti-infectives: Lipopeptide antifungal agents

Expert opinion on investigational drugs, 1994-02, Vol.3 (2), p.65-82

Balkovec, James M

1994

Volltextzugriff (PDF)

On the use of the O-methylmandelate ester for establishment of absolute configuration of secondary alcohols

Journal of organic chemistry, 1986-06, Vol.51 (12), p.2370-2374

1986

Volltextzugriff (PDF)

4-Methyl-5-phenyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I

Bioorganic & medicinal chemistry, 2008-06, Vol.18 (11), p.3405-3411

2008

Volltextzugriff (PDF)

Discovery of a Potent and Selective DGAT1 Inhibitor with a Piperidinyl-oxy-cyclohexanecarboxylic Acid Moiety

ACS medicinal chemistry letters, 2014-10, Vol.5 (10), p.1082-1087

2014

Volltextzugriff (PDF)

Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11β-HSD1: Novel therapeutic agents for the treatment of metabolic syndrome

Bioorganic & medicinal chemistry letters, 2005-12, Vol.15 (23), p.5266-5269

2005

Volltextzugriff (PDF)

Synthesis and Antifungal Activity of Novel Cationic Pneumocandin Bo Derivatives

Journal of medicinal chemistry, 1994-01, Vol.37 (2), p.222-225

1994

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(69)
Buchkapitel
(3)

Sprache

Englisch
(72)
Japanisch
(12)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Discovery and development of first in class antifungal caspofungin (CANCIDAS®)-A case study

Bifunctional Small Molecules Enhance Neutrophil Activities Against Aspergillus fumigatus in vivo and in vitro

Preclinical Evaluation of the Stability, Safety, and Efficacy of CD101, a Novel Echinocandin

The First Stereoselective Total Synthesis of Quinine

The use of stable-isotopically labeled oleic acid to interrogate lipid assembly in vivo: assessing pharmacological effects in preclinical species

Ibrexafungerp: An orally active β-1,3-glucan synthesis inhibitor

Development of Novel Immunoprophylactic Agents against Multidrug-Resistant Gram-Negative Bacterial Infections

Novel N-Arylpyrazolo[3,2-c]-Based Ligands for the Glucocorticoid Receptor: Receptor Binding and in Vivo Activity

11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice

MK-5204: An orally active β-1,3-glucan synthesis inhibitor

CTC-177, a novel drug–Fc conjugate, shows promise as an immunoprophylactic agent against multidrug-resistant Gram-negative bacterial infections

Accelerating the discovery of DGAT1 inhibitors through the application of parallel medicinal chemistry (PMC)

Novel orally active inhibitors of β-1,3-glucan synthesis derived from enfumafungin

Benzimidazole-based DGAT1 inhibitors with a [3.1.0] bicyclohexane carboxylic acid moiety

Synthesis and biological evaluation of antifungal derivatives of enfumafungin as orally bioavailable inhibitors of β-1,3-glucan synthase

11 beta -HSD1 inhibition reduces atherosclerosis in mice by altering proinflammatory gene expression in the vasculature

Phenylcyclobutyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I

Adamantyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1

11β-HSD1 inhibition reduces atherosclerosis in mice by altering proinflammatory gene expression in the vasculature

Section Review: Anti-infectives: Lipopeptide antifungal agents

On the use of the O-methylmandelate ester for establishment of absolute configuration of secondary alcohols

4-Methyl-5-phenyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I

Discovery of a Potent and Selective DGAT1 Inhibitor with a Piperidinyl-oxy-cyclohexanecarboxylic Acid Moiety

Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11β-HSD1: Novel therapeutic agents for the treatment of metabolic syndrome

Synthesis and Antifungal Activity of Novel Cationic Pneumocandin Bo Derivatives

Suchergebnisse filtern